The study titled “Long-term safety analysis of the BBV152 coronavirus vaccine in adolescents and adults: findings from a 1-year prospective study in north India,” which was published in May 2024 in the journal Drug Safety, was retracted and removed on September 24. Announcing the retraction, the journal editor stated that the article was being retracted…
NEW DELHI: Researchers from Banaras Hindu University (BHU) have conducted a one-year follow-up study on individuals who received Bharat Biotech’s Covaxin. The study revealed that approximately one-third of the participants experienced ‘adverse events of special interest’ (AESI) after receiving the vaccine. Dr Rajiv Bahl, the director general of ICMR, has responded to the study by…
NEW DELHI: Nearly 3 out of 10 people in India, aged between 18 and 54 years, have never got their blood pressure measured.This has been revealed by the ICMR – National Centre for Disease Informatics and Research (ICMR-NCDIR) in a study published recently in the International Journal of Public Health (IJPH).According to the ICMR-NCDIR study,…
MUMBAI: The majority of the country’s sickest patients may no longer benefit from carbapenem, an antibiotic that effectively treated pneumonia and septicemia until a decade back, according to the latest Indian Council of Medical Research (ICMR) study on antimicrobial resistance.The study, released on Friday, found that abuse of antimicrobials — be they antibiotics, antivirals or…
